Press Releases Archives - Page 13 of 103 - Lupin

BSE 2327.55 NSE 2323.00

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2327.55 NSE 2323.00

Lupin’s Alliance Partner ForDoz Receives U.S. FDA Approval for Doxorubicin Hydrochloride Liposome Injection

Lupin and Huons Sign License and Supply Agreement for Commercialization of Cyclosporine Ophthalmic Nanoemulsionin Mexico

Lupin Receives Tentative Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets

Lupin Receives Approval from U.S. FDA for Topiramate Extended-Release Capsules

Lupin Receives EIR from U.S. FDA for its Dabhasa Facility

Lupin Receives Tentative Approval from U.S. FDA for Empagliflozin, Linagliptin and Metformin Hydrochloride Extended-Release Tablets

Lupin Receives Tentative Approval from U.S. FDA for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)

Lupin Receives EIR from U.S. FDA for its Somerset Manufacturing Facility

Lupin Appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary

Lupin Announces Closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations

1 2 … 12 13 14 … 102 103

Search

Hit enter to search or ESC to close